15 results on '"Diao, Yong-Kang"'
Search Results
2. Short- and long-term outcomes of laparoscopic versus open liver resection for large hepatocellular carcinoma: a propensity score study.
- Author
-
Zhang, Kang-Jun, Liang, Lei, Diao, Yong-Kang, Xie, Ya-Ming, Wang, Dong-Dong, Xu, Fei-Qi, Ye, Tai-Wei, Lu, Wen-Feng, Cheng, Jian, Shen, Guo-Liang, Yao, Wei-Feng, Lu, Yi, Xiao, Zun-Qiang, Zhang, Jun-Gang, Zhang, Cheng-Wu, Huang, Dong-Sheng, and Liu, Jun-Wei
- Subjects
- *
LIVER surgery , *LAPAROSCOPIC surgery , *PROPENSITY score matching , *SURGICAL complications , *LIVER , *PATIENT selection - Abstract
Purpose: Laparoscopic liver resection (LLR) for hepatocellular carcinoma (HCC) remains controversial, especially for tumors larger than 5 cm. We compared the short- and long-term outcomes of laparoscopic and open liver resection (OLR) for large HCC. Methods: Patients with large HCC after curative hepatectomy were enrolled. To compare the short-term outcomes, propensity score matching (PSM) and inverse probability treatment weighting (IPTW) were performed to reduce the effect of confounding factors, respectively. Subsequently, Cox-regression analyses were conducted to identify the independent risk factors associated with decreased recurrence-free survival (RFS) and poor overall survival (OS). Result: There were 265 patients enrolled in the final analysis: 146 who underwent OLR and 119 who underwent LLR. There was no significant difference between the OLR and LLR groups according to PSM and IPTW analysis (all P > 0.05). Multivariable analysis revealed that LLR was not independently associated with poorer OS (HR 1.15, 95% CI 0.80–1.67, P = 0.448) or RFS (HR 1.22, 95% CI 0.88–1.70, P = 0.238). Conclusion: There were no significant differences in perioperative complications or long-term prognosis between LLR and OLR for large HCC, which provides evidence for standard laparoscopic surgical practice with adequate surgeon experience and careful patient selection. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. Is Serum Transferrin an Independent Predictor of Mortality in Severe Alcoholic Hepatitis?
- Author
-
Diao, Yong-Kang, Jia, Hang-Dong, Huang, Dong-Sheng, Zhang, Cheng-Wu, and Liang, Lei
- Subjects
- *
SERUM , *TRANSFERRIN , *ALCOHOLIC liver diseases - Published
- 2020
- Full Text
- View/download PDF
4. Comment on: Impact of anastomotic leak on long‐term survival in patients undergoing gastrectomy for gastric cancer.
- Author
-
Diao, Yong‐Kang, Jia, Hang‐Dong, Huang, Dong‐Sheng, Zhang, Cheng‐Wu, and Liang, Lei
- Subjects
- *
STOMACH cancer , *SURGICAL complications - Published
- 2020
- Full Text
- View/download PDF
5. Prognostic significance of nodular number in patients undergoing hepatectomy of intermediate-stage hepatocellular carcinoma.
- Author
-
Fan, Zhong-Qi, Serenari, Matteo, Lv, Xing, Schwartz, Myron, Qiu, Wei, Pawlik, Timothy M, Chen, Zhong, Zhou, Ya-Hao, Wang, Xian-Ming, Chen, Ting-Hao, Li, Jie, Zhang, Cheng-Wu, Wang, Hong, Zhang, Yao-Ming, Gu, Wei-Min, Liang, Ying-Jian, Diao, Yong-Kang, Yao, Lan-Qing, Li, Chao, and Cescon, Matteo
- Subjects
- *
HEPATOCELLULAR carcinoma , *CHEMOEMBOLIZATION , *HEPATECTOMY , *SURGICAL blood loss , *PATIENT selection , *SURGERY - Abstract
This article, published in the British Journal of Surgery, examines the importance of nodular number in predicting the prognosis of patients with intermediate-stage hepatocellular carcinoma (HCC) who undergo hepatectomy. The study, conducted at multiple hepatobiliary centers in China, Italy, and the USA, analyzed data from HCC patients who had undergone curative-intent hepatic resection between 2008 and 2018. The findings indicate that patients with three or more tumor nodules had lower overall survival and recurrence-free survival rates compared to those with two nodules. The study suggests that nodular number should be considered when predicting long-term prognosis after hepatic resection for intermediate-stage HCC. However, further research is needed to validate these findings. The study was supported by various funding sources and the authors have no conflicts of interest. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
6. Survival benefits from adjuvant transcatheter arterial chemoembolization in patients undergoing liver resection for hepatocellular carcinoma: a systematic review and meta-analysis.
- Author
-
Liang, Lei, Li, Chao, Diao, Yong-Kang, Jia, Hang-Dong, Xing, Hao, Pawlik, Timothy M., Lau, Wan Yee, Shen, Feng, Huang, Dong-Sheng, Zhang, Cheng-Wu, and Yang, Tian
- Subjects
- *
CHEMOEMBOLIZATION , *HEPATOCELLULAR carcinoma , *RANDOMIZED controlled trials , *PROGRESSION-free survival , *PORTAL vein , *LIVER - Abstract
Background: Although adjuvant transcatheter arterial chemoembolization (TACE) has been used to prevent recurrence after surgery in patients with hepatocellular carcinoma (HCC), the survival benefits from adjuvant TACE remain controversial. We sought to systematically evaluate the data on the effectiveness of adjuvant TACE for HCC, as well as identify patient populations that might benefit from adjuvant TACE. Methods: The PubMed, Embase, Medline and Cochrane library were systematically searched for studies published before July 2019 that compared adjuvant TACE versus surgery alone for HCC. The study endpoints were overall survival (OS) and disease-free survival (DFS). Patients with large HCC (⩾5 cm), multinodular HCC, microvascular invasion (MVI), or portal vein tumor thrombosis (PVTT) were analyzed in subgroup analyses. Results: Twenty-four studies with 6977 patients were included in the analytic cohort. The pooled analysis demonstrated that adjuvant TACE was associated with a better OS and DFS [hazard ratio (HR): 0.67 and 0.67, both p < 0.01]. In subgroup analyses, pooled results revealed that adjuvant TACE was associated with an improved OS and DFS in patients with multinodular HCC (HR: 0.79 and 0.31, both p < 0.01), MVI (HR: 0.62 and 0.67, both p < 0.01), or PVTT (HR: 0.49 and 0.58, both p < 0.01), but not among patients with large HCC (⩾5 cm). Conclusion: Postoperative adjuvant TACE may be effective to improve OS and DFS in patients with multinodular HCC, or HCC with MVI or PVTT. Future randomized controlled trials are needed to better define the benefit of adjuvant TACE in subset patients with HCC. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
7. Survival benefits from adjuvant transcatheter arterial chemoembolization in patients undergoing liver resection for hepatocellular carcinoma: a systematic review and meta-analysis.
- Author
-
Liang, Lei, Li, Chao, Diao, Yong-Kang, Jia, Hang-Dong, Xing, Hao, Pawlik, Timothy M., Lau, Wan Yee, Shen, Feng, Huang, Dong-Sheng, Zhang, Cheng-Wu, and Yang, Tian
- Subjects
- *
CHEMOEMBOLIZATION , *HEPATOCELLULAR carcinoma , *RANDOMIZED controlled trials , *PORTAL vein , *PROGRESSION-free survival , *LIVER - Abstract
Background: Although adjuvant transcatheter arterial chemoembolization (TACE) has been used to prevent recurrence after surgery in patients with hepatocellular carcinoma (HCC), the survival benefits from adjuvant TACE remain controversial. We sought to systematically evaluate the data on the effectiveness of adjuvant TACE for HCC, as well as identify patient populations that might benefit from adjuvant TACE. Methods: The PubMed, Embase, Medline and Cochrane library were systematically searched for studies published before July 2019 that compared adjuvant TACE versus surgery alone for HCC. The study endpoints were overall survival (OS) and disease-free survival (DFS). Patients with large HCC (⩾5 cm), multinodular HCC, microvascular invasion (MVI), or portal vein tumor thrombosis (PVTT) were analyzed in subgroup analyses. Results: Twenty-four studies with 6977 patients were included in the analytic cohort. The pooled analysis demonstrated that adjuvant TACE was associated with a better OS and DFS [hazard ratio (HR): 0.67 and 0.67, both p < 0.01]. In subgroup analyses, pooled results revealed that adjuvant TACE was associated with an improved OS and DFS in patients with multinodular HCC (HR: 0.79 and 0.31, both p < 0.01), MVI (HR: 0.62 and 0.67, both p < 0.01), or PVTT (HR: 0.49 and 0.58, both p < 0.01), but not among patients with large HCC (⩾5 cm). Conclusion: Postoperative adjuvant TACE may be effective to improve OS and DFS in patients with multinodular HCC, or HCC with MVI or PVTT. Future randomized controlled trials are needed to better define the benefit of adjuvant TACE in subset patients with HCC. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
8. Prospective validation of the Eastern Staging in predicting survival after surgical resection for patients with hepatocellular carcinoma: a multicenter study from China.
- Author
-
Yang, Shun-Chao, Liang, Lei, Wang, Ming-Da, Wang, Xian-Ming, Gu, Li-Hui, Lin, Kong-Ying, Zhou, Ya-Hao, Chen, Ting-Hao, Gu, Wei-Min, Li, Jie, Wang, Hong, Chen, Zhong, Li, Chao, Yao, Lan-Qing, Diao, Yong-Kang, Sun, Li-Yang, Zhang, Cheng-Wu, Zeng, Yong-Yi, Lau, Wan Yee, and Huang, Dong-Sheng
- Subjects
- *
SURGICAL excision , *HEPATOCELLULAR carcinoma , *AKAIKE information criterion , *OVERALL survival , *TUMOR classification - Abstract
The Eastern Staging System, which was specially developed for patients undergoing surgical resection for hepatocellular carcinoma (HCC), has been proposed for more than ten years. To prospectively validate the predictive accuracy of the Eastern staging on long-term survival after HCC resection. Patients who underwent hepatectomy for HCC from 2011 to 2020 at 10 Chinese hospitals were identified from a prospectively collected database. The survival predictive accuracy was evaluated and compared between the Eastern Staging with six other staging systems, including the JIS, BCLC, Okuda, CLIP, 8th AJCC TNM, and HKLC staging. Among 2365 patients, the 1-, 3-, and 5-year overall survival rates were 84.2%, 64.5%, and 52.6%, respectively. Among these seven staging systems, the Eastern staging was associated with the best monotonicity of gradients (linear trend χ2: 408.5) and homogeneity (likelihood ratio χ2: 447.3), and the highest discriminatory ability (the areas under curves for 1-, 3-, and 5-year mortality: 0.776, 0.787, and 0.768, respectively). In addition, the Eastern staging was the most informative staging system in predicting survival (Akaike information criterion: 2982.33). Using a large multicenter prospectively collected database, the Eastern Staging was found to show the best predictive accuracy on long-term overall survival in patients with resectable HCC than the other 6 commonly-used staging systems. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. Association of Adjuvant Radiation Therapy With Long-Term Overall and Recurrence-Free Survival After Hepatectomy for Hepatocellular Carcinoma: A Multicenter Propensity-Matched Study.
- Author
-
Gou, Xiao-Xue, Shi, Hong-Yun, Li, Chao, Chen, Zheng-Liang, Ouyang, Wei, Sun, Li-Yang, Diao, Yong-Kang, Wang, Ming-Da, Yao, Lan-Qing, Gu, Li-Hui, Pawlik, Timothy M., Lau, Wan Yee, Shen, Feng, Xue, Jun, and Yang, Tian
- Subjects
- *
RADIOTHERAPY , *SURGICAL margin , *HEPATOCELLULAR carcinoma , *OVERALL survival , *HEPATECTOMY , *PROPENSITY score matching , *RESEARCH , *LIVER tumors , *RESEARCH methodology , *CANCER relapse , *RETROSPECTIVE studies , *EVALUATION research , *COMPARATIVE studies , *PROBABILITY theory - Abstract
Purpose: R0 resection with a wide surgical margin is the gold standard for hepatocellular carcinoma (HCC), yet R0 resection with narrow margins and even R1 resection is not uncommon in real-world clinical practice. We sought to use a propensity-matched analysis to characterize the efficacy of adjuvant radiation therapy on long-term oncological survival after hepatectomy for HCC with narrow or positive margins.Methods and Materials: Using a multi-institutional database, patients with HCC who underwent hepatectomy with negative margins of 0.1 to 1.0 cm or pathologically positive margins were analyzed. Using propensity score matching (PSM) and multivariate Cox-regression analysis, the effect of adjuvant radiation therapy on long-term overall survival (OS) and recurrence-free survival (RFS) was evaluated.Results: Among 683 patients who met inclusion criteria, 82 patients received adjuvant radiation therapy within 10 weeks after surgery. Radiation therapy-related major toxic effects were minimal among patients receiving adjuvant radiation therapy. PSM analysis created 78 matched pairs of patients. In the PSM cohort, median OS and RFS among patients treated with adjuvant radiation therapy were more favorable than individuals who were not treated (72.5 and 37.3 months versus 52.5 and 24.0 months, both P < .05). After adjustment for other confounding factors on multivariate analyses, adjuvant radiation therapy remained independently associated with favorable OS and RFS after hepatectomy with close/positive surgical margins for HCC (hazard ratios, 0.821 and 0.827, respectively).Conclusions: Despite the lack of consensus on the role of adjuvant radiation therapy after HCC resection, this PSM analysis suggested improved OS and RFS with adjuvant radiation therapy after hepatectomy with close/positive surgical margins for HCC. Future randomized controlled trials are needed to further define the survival benefit of adjuvant radiation therapy for patients with HCC. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
10. Development and validation of a novel online calculator for estimating survival benefit of adjuvant transcatheter arterial chemoembolization in patients undergoing surgery for hepatocellular carcinoma.
- Author
-
Liang, Lei, Li, Chao, Wang, Ming-Da, Wang, Hong, Zhou, Ya-Hao, Zeng, Yong-Yi, Zhang, Wan-Guang, Chen, Ting-Hao, Wang, Nan-Ya, Li, Jie, Zhang, Yao-Ming, Wang, Yu, Gu, Wei-Min, Xing, Hao, Diao, Yong-Kang, Lau, Wan Yee, Zhang, Cheng-Wu, Pawlik, Timothy M., Shen, Feng, and Huang, Dong-Sheng
- Subjects
- *
CHEMOEMBOLIZATION , *HEPATOCELLULAR carcinoma , *SURGICAL margin , *PORTAL hypertension , *CALCULATORS , *PREDICTION models - Abstract
Background and aims: Although adjuvant transcatheter arterial chemoembolization (TACE) for resected hepatocellular carcinoma (HCC) may improve survival for some patients, identifying which patients can benefit remains challenging. The present study aimed to construct a survival prediction calculator for individualized estimating the net survival benefit of adjuvant TACE for patients with resected HCC. Methods: From a multicenter database, consecutive patients undergoing curative resection for HCC were enrolled and divided into the developing and validation cohorts. Using the independent survival predictors in the developing cohort, two nomogram models were constructed for patients with and without adjuvant TACE, respectively, which predictive performance was validated internally and externally by measuring concordance index (C-index) and calibration. The difference between two estimates of the prediction models was the expected survival benefit of adjuvant TACE. Results: A total of 2514 patients met the inclusion criteria for the study. The nomogram prediction models for patients with and without adjuvant TACE were, respectively, built by incorporating the same eight independent survival predictors, including portal hypertension, Child–Pugh score, alpha-fetoprotein level, tumor size and number, macrovascular and microvascular invasion, and resection margin. These two prediction models demonstrated good calibration and discrimination, with all the C-indexes of greater than 0.75 in the developing and validation cohorts. A browser-based calculator was generated for individualized estimating the net survival benefit of adjuvant TACE. Conclusions: Based on large-scale real-world data, an easy-to-use online calculator can be adopted as a decision aid to predict which patients with resected HCC can benefit from adjuvant TACE. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
11. The value of lymphadenectomy in surgical resection of perihilar cholangiocarcinoma: a systematic review and meta-analysis.
- Author
-
Liang, Lei, Li, Chao, Wang, Ming-Da, Xing, Hao, Diao, Yong-Kang, Jia, Hang-Dong, Lau, Wan Yee, Pawlik, Timothy M., Zhang, Cheng-Wu, Shen, Feng, Huang, Dong-Sheng, and Yang, Tian
- Subjects
- *
LYMPHADENECTOMY , *SURGICAL excision , *PROGNOSIS , *CHOLANGIOCARCINOMA , *LYMPHATIC metastasis , *LYMPH nodes - Abstract
Surgical resection is the only potentially curative treatment for patients with resectable perihilar cholangiocarcinoma (PHC). There is still no consensus on the value of lymphadenectomy despite evidence indicating lymph node (LN) status is an important prognostic indicator for postoperative long-term survival. We sought to perform a meta-analysis to summarize the current evidence on the value of lymphadenectomy among patients undergoing surgery for PHC. The PubMed (OvidSP), Embase and Cochrane Library were systematically searched for studies published before July 2020 that reported on lymphadenectomy at the time of surgery for PHC after curative surgery. 7748 patients from 28 studies were included in the meta-analysis. No survival benefit was identified with increased number of LN resected (all P > 0.05). Meanwhile, overall LN status was an important prognostic factor. Patients with lymph node metastasis had a pooled estimate hazard ratio of death that was over two-fold higher than patients without lymph node metastasis (HR 2.07, 95% CI 1.65–2.59, P < 0.001). The examination of 5 LNs on histology was associated with better staging of lymph node status and stratification of patients into positive or negative LN groups. While the extent of LN dissection was not associated with a survival benefit, examination of more than 5 LNs better staged patients into positive or negative LN groups with a lower risk of nodal understaging. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
12. Prognostic factors of resectable perihilar cholangiocarcinoma: a systematic review and meta-analysis of high-quality studies.
- Author
-
Liang, Lei, Li, Chao, Jia, Hang-Dong, Diao, Yong-Kang, Xing, Hao, Pawlik, Timothy M., Lau, Wan Yee, Shen, Feng, Huang, Dong-Sheng, Zhang, Cheng-Wu, and Yang, Tian
- Subjects
- *
INFORMATION storage & retrieval systems , *MEDICAL databases , *MEDICAL information storage & retrieval systems , *MEDLINE , *META-analysis , *ONLINE information services , *SURVIVAL , *SYSTEMATIC reviews , *CHOLANGIOCARCINOMA ,BILE duct tumors - Abstract
Data on prognostic factors associated with outcome following resection of perihilar cholangiocarcinoma vary. We sought to define and characterize current available evidence on prognostic factors associated with perihilar cholangiocarcinoma after resection. The PubMed, Embase, and Cochrane library were systematically searched for relevant studies published before December 2019. Prognostic factors were identified from multivariate regression analyses in studies. Only high-quality studies were included (Newcastle–Ottawa Scale > 6 stars). A total of 45 studies involving 7338 patients were analyzed. The meta-analysis demonstrated that serum bilirubin levels (hazard ratio: 1.76, 95% confidence interval: 1.27–2.44), serum CA19-9 levels (hazard ratio: 1.32, 95% confidence interval: 1.05–1.65), tumor size (hazard ratio: 1.27, 95% confidence interval: 1.04–1.55), major vascular involvement (hazard ratio: 1.61, 95% confidence interval: 1.09–2.38), distance metastasis (hazard ratio: 17.60, 95% confidence interval: 2.01–154.09), perioperative blood transfusion (hazard ratio: 1.36, 95% confidence interval: 1.15–1.62), T-stage (hazard ratio: 1.96, 95% confidence interval: 1.47–2.61), lymph node metastasis (hazard ratio: 2.06, 1.83–2.31), resection margin status (hazard ratio: 2.34, 95% confidence interval: 1.89–2.89), not-well histology differentiation (hazard ratio: 2.03, 95% confidence interval: 1.69–2.44), perineural invasion (hazard ratio: 2.37, 95% confidence interval: 1.59–3.55), and lymphovascular invasion (hazard ratio: 1.41, 95% confidence interval: 1.15–1.73) were prognostic factors for poorer overall survival. Adjuvant chemotherapy (hazard ratio: 0.37, 95% confidence interval: 0.25–0.55) had a positive effect on prolonged overall survival. In addition, positive resection margin status (hazard ratio: 1.96, 95% confidence interval: 1.47–2.61) and lymph node metastasis (hazard ratio: 2.06, 95% confidence interval: 1.83–2.31) were associated with poorer disease-free survival. The prognostic factors identified in the present meta-analysis can be used to characterize patients in clinical practice and enrich prognostic tools, which could be included in future trial designs and generate hypotheses to be tested in future research to promote personalized treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
13. Prognostic factors of resectable perihilar cholangiocarcinoma: a systematic review and meta-analysis of high-quality studies.
- Author
-
Liang, Lei, Li, Chao, Jia, Hang-Dong, Diao, Yong-Kang, Xing, Hao, Pawlik, Timothy M., Lau, Wan Yee, Shen, Feng, Huang, Dong-Sheng, Zhang, Cheng-Wu, and Yang, Tian
- Subjects
- *
ONLINE information services , *SURVIVAL , *META-analysis , *MEDICAL information storage & retrieval systems , *MEDICAL databases , *INFORMATION storage & retrieval systems , *CONFIDENCE intervals , *SYSTEMATIC reviews , *BILE duct adenocarcinoma , *MEDLINE , *BILIRUBIN - Abstract
Data on prognostic factors associated with outcome following resection of perihilar cholangiocarcinoma vary. We sought to define and characterize current available evidence on prognostic factors associated with perihilar cholangiocarcinoma after resection. The PubMed, Embase, and Cochrane library were systematically searched for relevant studies published before December 2019. Prognostic factors were identified from multivariate regression analyses in studies. Only high-quality studies were included (Newcastle–Ottawa Scale > 6 stars). A total of 45 studies involving 7338 patients were analyzed. The meta-analysis demonstrated that serum bilirubin levels (hazard ratio: 1.76, 95% confidence interval: 1.27–2.44), serum CA19-9 levels (hazard ratio: 1.32, 95% confidence interval: 1.05–1.65), tumor size (hazard ratio: 1.27, 95% confidence interval: 1.04–1.55), major vascular involvement (hazard ratio: 1.61, 95% confidence interval: 1.09–2.38), distance metastasis (hazard ratio: 17.60, 95% confidence interval: 2.01–154.09), perioperative blood transfusion (hazard ratio: 1.36, 95% confidence interval: 1.15–1.62), T-stage (hazard ratio: 1.96, 95% confidence interval: 1.47–2.61), lymph node metastasis (hazard ratio: 2.06, 1.83–2.31), resection margin status (hazard ratio: 2.34, 95% confidence interval: 1.89–2.89), not-well histology differentiation (hazard ratio: 2.03, 95% confidence interval: 1.69–2.44), perineural invasion (hazard ratio: 2.37, 95% confidence interval: 1.59–3.55), and lymphovascular invasion (hazard ratio: 1.41, 95% confidence interval: 1.15–1.73) were prognostic factors for poorer overall survival. Adjuvant chemotherapy (hazard ratio: 0.37, 95% confidence interval: 0.25–0.55) had a positive effect on prolonged overall survival. In addition, positive resection margin status (hazard ratio: 1.96, 95% confidence interval: 1.47–2.61) and lymph node metastasis (hazard ratio: 2.06, 95% confidence interval: 1.83–2.31) were associated with poorer disease-free survival. The prognostic factors identified in the present meta-analysis can be used to characterize patients in clinical practice and enrich prognostic tools, which could be included in future trial designs and generate hypotheses to be tested in future research to promote personalized treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
14. Impact of Mesh Selection During Ventral Hernia Repair on Postoperative Surgical Site Infection and Hernia Recurrence.
- Author
-
Liang, Lei, Sun, Li-Yang, Diao, Yong-Kang, Jia, Hang-Dong, and Yang, Tian
- Subjects
- *
SURGICAL meshes , *VENTRAL hernia , *SURGICAL site infections , *HERNIA - Published
- 2020
- Full Text
- View/download PDF
15. Letter: are opioid prescriptions associated with hepatic encephalopathy in patients with compensated cirrhosis?
- Author
-
Li, Chao, Liang, Lei, Jia, Hang‐Dong, Diao, Yong‐Kang, and Yang, Tian
- Subjects
- *
HEPATIC encephalopathy , *CIRRHOSIS of the liver , *PRESCRIPTION writing , *LETTERS , *OPIOID analgesics - Abstract
LINKED CONTENT This article is linked to Moon et al papers. To view these articles, visit https://doi.org/10.1111/apt.15639 and https://doi.org/10.1111/apt.15669. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.